• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: presented

    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH:
    Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

    Susan O’Brien
    Susan O’Brien

    SUSAN O’BRIEN, MD Anderson Cancer Center, Houston
    For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology
    …
    Read more
    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

    Pierre Fenaux
    Pierre Fenaux

    PIERRE FENAUX, Paris 13 University
    Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
    …
    Read more
  • Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
    • in Cardiovascular
    • — 5 Nov, 2007

    Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

    Laura Mauri
    Laura Mauri
    Raymond Gibbons
    Raymond Gibbons

    REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts
    COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota

    The largest study to date looking
    …
    Read more
    Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
    • in Cardiovascular
    • — 5 Nov, 2007

    Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results

    REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    LESLEE SHAW, Emory University, Atlanta
    COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson

    Some patients with stable angina may be best …

    Read more
  • Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
    • in Oncology
    • — 16 Oct, 2007

    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

    Jose Baselga
    Jose Baselga
    Gordon McVie
    Gordon McVie

    REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    Neoadjuvant trastuzumab for patients with HER2-positive
    …
    Read more
    Vancomycin: New Guidelines May Induce Kidney Damage
    • in Public Health
    • — 19 Sep, 2007

    Vancomycin: New Guidelines May Induce Kidney Damage

    Megan Nguyen
    Megan Nguyen

    REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    MEGAN NGUYEN, Western University in Pomona, California
    New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
    …
    Read more
  • Virus Plus Cytokine Fight Primary and Metastatic Cancer
    • in Oncology
    • — 15 Aug, 2007

    Virus Plus Cytokine Fight Primary and Metastatic Cancer

    Paul Fisher
    Paul Fisher

    REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles
    PAUL FISHER, Columbia University, New York
    Patients with cancer could soon be treated with adenoviruses capable of infecting both primary and distant tumors, and simultaneously releasing cancer-fighting cytokines, according
    …
    Read more
    Fire Ants: Purveyors of Pain, or Possible Source of New Antimicrobials?
    • in ICAAC 2005
    • — 7 Jan, 2006

    Fire Ants: Purveyors of Pain, or Possible Source of New Antimicrobials?

    Heather White
    Heather White

    Heather White, University of Mississippi Medical Center, Jackson
    If you have ever been bitten by a fire ant you’ll remember the pain! But a study presented in Washington has shown that when they sting, they produce substances with …

    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: presented

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.